Stay updated on VS-6766 and Everolimus Clinical Trial

Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VS-6766 and Everolimus Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record for a Phase I study of VS-6766 alone and with everolimus is now displayed, including study design, participant criteria, treatment schedules, and outcome measures. The record indicates that the study is completed and is no longer recruiting participants.
    Difference
    73%
    Check dated 2026-11-09T14:48:53.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page rather than showing the clinical study record. The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T16:23:46.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says agencies are adopting “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T16:32:02.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T21:44:43.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-13T04:21:18.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study content, preventing access to the record and its details; as a result, the page’s core information is no longer retrievable by users.
    Difference
    22%
    Check dated 2026-09-21T22:08:49.000Z thumbnail image

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.